SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018101
Filing Date
2018-07-31
Accepted
2018-07-31 16:03:36
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20180630.htm 10-Q 1715900
2 EX-31.1 gern-ex311_6.htm EX-31.1 17409
3 EX-31.2 gern-ex312_8.htm EX-31.2 17429
4 EX-32.1 gern-ex321_7.htm EX-32.1 7636
5 EX-32.2 gern-ex322_9.htm EX-32.2 7622
  Complete submission text file 0001564590-18-018101.txt   5970616

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gern-20180630.xml EX-101.INS 1551545
7 XBRL TAXONOMY EXTENSION SCHEMA gern-20180630.xsd EX-101.SCH 29507
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20180630_cal.xml EX-101.CAL 28772
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20180630_def.xml EX-101.DEF 99367
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20180630_lab.xml EX-101.LAB 245019
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20180630_pre.xml EX-101.PRE 173966
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1117
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 18981131
SIC: 2834 Pharmaceutical Preparations